University of Pennsylvania - Abramson Cancer Center — Philadelphia, Pennsylvania

University of Pennsylvania - Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Pennsylvania - Abramson Cancer Center has participated in 8 clinical trials with 5 currently active.

Therapeutic areas: Head and Neck Cancer, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma.

Sponsors: MacroGenics, InSilico Medicine Hong Kong Limited, Priothera SAS.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania - Abramson Cancer Center?

University of Pennsylvania - Abramson Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania - Abramson Cancer Center conducted?

University of Pennsylvania - Abramson Cancer Center has 8 clinical trials on record, with 5 currently active. Their work covers Head and Neck Cancer, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma.

Is University of Pennsylvania - Abramson Cancer Center accredited by Crixeo Health?

Yes — University of Pennsylvania - Abramson Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Pennsylvania - Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.